Clinical Trial Update: PCSK9 Inhibitors in the Progression of Aortic Stenosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating PCSK9 inhibitors for slowing the progression of aortic valve stenosis. The status of the study is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• PCSK9 inhibitors

Snippet

Sponsor: Seoul National University Hospital | Conditions: Aortic Valve Stenosis | Phase 2 | Status: UNKNOWN